Microbot Medical MBOT Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's financing cash flow?
- Microbot Medical (MBOT) reported financing cash flow of $2.51M in Q4 2025.
- How has Microbot Medical's financing cash flow changed year-over-year?
- Microbot Medical's financing cash flow decreased by 11.5% year-over-year, from $2.83M to $2.51M.
- What is the long-term trend for Microbot Medical's financing cash flow?
- Over 3 years (2022 to 2025), Microbot Medical's financing cash flow has grown at a 171.2% compound annual growth rate (CAGR), from $4.32M to $86.24M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.